
D.
4576.TD. Western Therapeutics Institute, Inc. Price (4576.T)
Stock Price
Market Cap
Fetching Data...
Enterprise Value
Fetching Data...
Volume
Fetching Data...
Shares Outstanding
35,118,450
(10.5047)%
Cash Flow Statement
D. Western Therapeutics Institute, Inc.Currency: JPY
YEAR | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Activities | |||||||||||||||||||
Net Income | 133.00M
+0% |
-289,527,000.00
-318% |
-159,711,000.00
-45% |
-440,267,000.00
+176% |
-812,000,000.00
+84% |
-1,290,305,000.00
+59% |
|||||||||||||
Depreciation And Amortiz... | 44.00M | 44.16M | 45.26M | 46.37M | 48.72M | 60.48M | |||||||||||||
Deferred Income Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||||||||||
Stock-Based Compensat... | 0.00 | 9.90M | 15.23M | 15.81M | 15.57M | 17.00M | |||||||||||||
Change In Working Capital | |||||||||||||||||||
Accounts Receivables | -32,000,000.00 | 11.00M | -9,000,000.00 | -113,000,000.00 | 53.61M | -7,879,000.00 | |||||||||||||
Accounts Payables | -5,050,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||||||||||
Inventory | 106.00k | 1.04M | -30,075,000.00 | 9.19M | 22.59M | -14,098,000.00 | |||||||||||||
Other Working Capital | 60.00M | 5.00M | -24,000,000.00 | 21.00M | 80.69M | 1.31M | |||||||||||||
Other Non-Cash Items | -30,000,000.00 | -6,909,000.00 | -17,854,000.00 | 38.66M | 4.00M | -65,627,000.00 | |||||||||||||
Net Cash Provided By Op... | 175.00M
+0% |
-216,284,000.00
-224% |
-176,306,000.00
-18% |
-354,770,000.00
+101% |
-586,821,000.00
+65% |
-1,299,118,000.00
+121% |
|||||||||||||
Investing Activities | |||||||||||||||||||
Investments In Propert... | 0.00 | -5,126,000.00 | -2,899,000.00 | -9,814,000.00 | -14,938,000.00 | -9,025,000.00 | |||||||||||||
Acquisitions Net | -100,000,000.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||||||||||
Purchases Of Investments | 0.00 | -7,868,000.00 | -109,148,000.00 | -130,200,000.00 | 0.00 | 0.00 | |||||||||||||
Sales Maturities Of Inve... | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||||||||||
Other Investing Activities | -100,000,000.00 | -471,000.00 | 897.00k | 124.00k | -316,000.00 | -980,000.00 | |||||||||||||
Net Cash Used For Inv... | -100,000,000.00
+0% |
-13,465,000.00
-87% |
-111,150,000.00
+725% |
-139,890,000.00
+26% |
-15,254,000.00
-89% |
-10,005,000.00
-34% |
|||||||||||||
Financing Activities | |||||||||||||||||||
Debt Repayment | -120,000,000.00 | -20,000,000.00 | -120,000,000.00 | 793.00M | 46.00M | -147,758,000.00 | |||||||||||||
Common Stock Issued | 0.00 | 1.02B | 16.62M | 99.90M | 88.99M | 0.00 | |||||||||||||
Common Stock Repurch... | 0.00 | 0.00 | -1,080,000.00 | -13,517,000.00 | 0.00 | -699,000.00 | |||||||||||||
Dividends Paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||||||||||
Other Financing Activities | 0.00 | 808.00k | 1,000.00 | -12,084,000.00 | -528,000.00 | 716.09M | |||||||||||||
Net Cash Used/Provide... | -120,000,000.00
+0% |
1.00B
-937% |
-104,459,000.00
-110% |
867.30M
-930% |
134.47M
-84% |
567.63M
+322% |
|||||||||||||
Effect Of Forex Changes... | 0.00 | -6,950,000.00 | 17.45M | 28.29M | 205.00k | 266.00k | |||||||||||||
Net Change In Cash | -1,629,282,000.00 | 767.43M | -374,467,000.00 | 400.93M | -467,404,000.00 | 1.13B | |||||||||||||
Cash At Beginning Of Per... | 1.58B | 1.54B | 2.31B | 1.93B | 2.33B | 0.00 | |||||||||||||
Cash At End Of Period | -45,000,000.00 | 2.31B | 1.93B | 2.33B | 1.87B | 1.13B | |||||||||||||
Additional Metrics: | |||||||||||||||||||
Operating Cash Flow | 175.00M | -216,284,000.00 | -176,306,000.00 | -354,770,000.00 | -586,821,000.00 | -1,299,118,000.00 | |||||||||||||
Capital Expenditure | 0.00 | -5,126,000.00 | -2,899,000.00 | -9,814,000.00 | -14,938,000.00 | -9,025,000.00 | |||||||||||||
Free Cash Flow | 175.00M
+0% |
-221,410,000.00
-227% |
-179,205,000.00
-19% |
-364,584,000.00
+103% |
-601,759,000.00
+65% |
-1,308,143,000.00
+117% |